SCHEMBL7698447

SCHEMBL7698447

CC(C)(CCCCO)CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
DUT P33316 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368374 0.86 DUT (0.30) DUT
SCHEMBL30840114 0.83 CYP4F2 (0.33) CYP4F2CYP4A11
SCHEMBL334934 0.82 DUT (0.38) CYP4F2CYP4A11DUT
SCHEMBL8622940 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL10930589 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL25304378 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL31399502 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL1143253 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL200311 0.80 DUT (0.37) CYP4F2CYP4A11DUT
SCHEMBL2883658 0.80 DUT (0.31) DUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed
EP-1056716-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 EP disclosed
WO-1999043646-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed